These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 16308681)

  • 1. Outcome in severely ill patients with hematological malignancies who received intravenous chemotherapy in the intensive care unit.
    Benoit DD; Depuydt PO; Vandewoude KH; Offner FC; Boterberg T; De Cock CA; Noens LA; Janssens AM; Decruyenaere JM
    Intensive Care Med; 2006 Jan; 32(1):93-9. PubMed ID: 16308681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors to predict outcome in critically ill cancer patients receiving chemotherapy in the intensive care unit.
    Song JU; Suh GY; Chung MP; Kim H; Kwon OJ; Jung CW; Kang WK; Park K; Jeon K
    Support Care Cancer; 2011 Apr; 19(4):491-5. PubMed ID: 20229331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of recent intravenous chemotherapy on outcome in severe sepsis and septic shock patients with hematological malignancies.
    Vandijck DM; Benoit DD; Depuydt PO; Offner FC; Blot SI; Van Tilborgh AK; Nollet J; Steel E; Noens LA; Decruyenaere JM
    Intensive Care Med; 2008 May; 34(5):847-55. PubMed ID: 18214437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Urgent Chemotherapy in Critically Ill Patients.
    de Oliveira MCF; Ferreira JC; Nassar Junior AP; Dettino ALA; Caruso P
    J Intensive Care Med; 2020 Apr; 35(4):347-353. PubMed ID: 29258386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of short and long-term outcome in patients with hematological disorders admitted to the intensive care unit for a life-threatening complication.
    Cherif H; Martling CR; Hansen J; Kalin M; Björkholm M
    Support Care Cancer; 2007 Dec; 15(12):1393-8. PubMed ID: 17516092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics and outcomes of patients with hematologic malignancies receiving chemotherapy in the intensive care unit.
    Pastores SM; Goldman DA; Shaz DJ; Kostelecky N; Daley RJ; Peterson TJ; Tan KS; Halpern NA
    Cancer; 2018 Jul; 124(14):3025-3036. PubMed ID: 29727916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome in critically ill medical patients treated with renal replacement therapy for acute renal failure: comparison between patients with and those without haematological malignancies.
    Benoit DD; Hoste EA; Depuydt PO; Offner FC; Lameire NH; Vandewoude KH; Dhondt AW; Noens LA; Decruyenaere JM
    Nephrol Dial Transplant; 2005 Mar; 20(3):552-8. PubMed ID: 15671075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematological malignancies in Polish population: what are the predictors of outcome in patients admitted to Intensive Care Unit?
    Kalicińska E; Kuszczak B; Dębski J; Szukalski Ł; Wątek M; Strzała J; Rybka J; Czyż J; Lech-Marańda E; Zaucha J; Wróbel T
    Support Care Cancer; 2021 Jan; 29(1):323-330. PubMed ID: 32361829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors and utility of scoring systems in patients with hematological malignancies admitted to the intensive care unit and required a mechanical ventilator.
    Nishida K; Palalay MP
    Hawaii Med J; 2008 Oct; 67(10):264-9. PubMed ID: 19097551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome and early prognostic indicators in patients with a hematologic malignancy admitted to the intensive care unit for a life-threatening complication.
    Benoit DD; Vandewoude KH; Decruyenaere JM; Hoste EA; Colardyn FA
    Crit Care Med; 2003 Jan; 31(1):104-12. PubMed ID: 12545002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes in critically ill patients with hematologic malignancies who received renal replacement therapy for acute kidney injury in an intensive care unit.
    Park MR; Jeon K; Song JU; Lim SY; Park SY; Lee JE; Huh W; Kim K; Kim WS; Jung CW; Suh GY
    J Crit Care; 2011 Feb; 26(1):107.e1-6. PubMed ID: 20813488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome and prognostic features of intensive care unit treatment in patients with hematological malignancies.
    Kroschinsky F; Weise M; Illmer T; Haenel M; Bornhaeuser M; Hoeffken G; Ehninger G; Schuler U
    Intensive Care Med; 2002 Sep; 28(9):1294-300. PubMed ID: 12209280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors, long-term survival, and outcome of cancer patients receiving chemotherapy in the intensive care unit.
    Wohlfarth P; Staudinger T; Sperr WR; Bojic A; Robak O; Hermann A; Laczika K; Carlström A; Riss K; Rabitsch W; Bojic M; Knoebl P; Locker GJ; Obiditsch M; Fuhrmann V; Schellongowski P;
    Ann Hematol; 2014 Oct; 93(10):1629-36. PubMed ID: 24997682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors in critically ill patients with hematologic malignancies admitted to the intensive care unit.
    Yeo CD; Kim JW; Kim SC; Kim YK; Kim KH; Kim HJ; Lee S; Rhee CK
    J Crit Care; 2012 Dec; 27(6):739.e1-6. PubMed ID: 23217573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relationship between procalcitonin serum levels and complications and outcome of patients with hematological malignancy admitted to Intensive Care Unit].
    Ferrà C; Lacoma A; García O; Marcos P; Domínguez J; Ribera JM
    Med Clin (Barc); 2012 Apr; 138(9):385-8. PubMed ID: 22257606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics and outcomes of patients with a haematological malignancy admitted to the intensive care unit for a neurological event.
    Riedijk M; van den Bergh WM; van Vliet M; Kusadasi N; Span LR; Tuinman PR; Arbous MS; Müller MC;
    Crit Care Resusc; 2015 Dec; 17(4):268-73. PubMed ID: 26640063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognosis-related factors in intensive care unit (ICU) patients with hematological malignancies: A retrospective cohort analysis in a Chinese population.
    Liu J; Cheng Q; Yang Q; Li X; Shen X; Zhang L; Liu Z; Khoshnood K
    Hematology; 2015 Oct; 20(9):494-503. PubMed ID: 25585045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there a role for inhaled nitric oxide as a rescue therapy in respiratory failure associated with hematologic malignancies?
    Keegan MT; Nygren E; Afessa B; Hogan WJ; Harrison BA
    Am J Hematol; 2006 Oct; 81(10):729-34. PubMed ID: 16838327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematologic malignancies in the medical intensive care unit--Outcomes and prognostic factors.
    Grgić Medić M; Gornik I; Gašparović V
    Hematology; 2015 Jun; 20(5):247-53. PubMed ID: 25310461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of noninvasive ventilation failure in patients with hematologic malignancy and acute respiratory failure.
    Adda M; Coquet I; Darmon M; Thiery G; Schlemmer B; Azoulay E
    Crit Care Med; 2008 Oct; 36(10):2766-72. PubMed ID: 18766110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.